What is Merck & Co.'s asia pacific (other than china and japan) — sales?

Merck & Co. (MRK) reported asia pacific (other than china and japan) — sales of $738.00M in Q1 2026.

How has Merck & Co.'s asia pacific (other than china and japan) — sales changed year-over-year?

Merck & Co.'s asia pacific (other than china and japan) — sales increased by 7.1% year-over-year, from $689.00M to $738.00M.

What is the long-term trend for Merck & Co.'s asia pacific (other than china and japan) — sales?

Over 4 years (2021 to 2025), Merck & Co.'s asia pacific (other than china and japan) — sales has grown at a 5.5% compound annual growth rate (CAGR), from $2.41B to $2.98B.

What does asia pacific (other than china and japan) — sales mean?

Total revenue earned from sales in the Asia Pacific region, excluding Japan and China.

Discontinued — last reported Q1 '26

Geographic · Sales

Asia Pacific (other than China and Japan) — Sales

Merck & Co. Asia Pacific (other than China and Japan) — Sales decreased by 0.9% to $738.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $689.00M to $738.00M. Over 4 years (FY 2021 to FY 2025), Asia Pacific (other than China and Japan) — Sales shows an upward trend with a 5.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityModerate

First reportedQ1 2016

Last reportedQ1 2026

Rolls up toTotal Revenue

How to read this metric

An increase indicates successful product adoption or market expansion in the region, while a decrease may signal competitive pressure, pricing challenges, or regulatory headwinds.

Detailed definition

This metric represents the total revenue generated from pharmaceutical and vaccine products within the specified Asia Pa...

Peer comparison

Peers typically report regional revenue segments to demonstrate geographic diversification and exposure to specific emerging market growth profiles.

Metric ID: mrk_segment_asia_pacific_other_than_japan_and_china_sales

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$594.00M	$613.00M	$449.00M	$930.00M	$1.01B	$854.00M	$822.00M	$846.00M	$848.00M	$781.00M	$750.00M	$724.00M	$748.00M	$823.00M	$763.00M	$689.00M	$785.00M	$764.00M	$745.00M	$738.00M
QoQ Change	—	+3.2%	-26.8%	+107.1%	+8.4%	-15.3%	-3.7%	+2.9%	+0.2%	-7.9%	-4.0%	-3.5%	+3.3%	+10.0%	-7.3%	-9.7%	+13.9%	-2.7%	-2.5%	-0.9%
YoY Change	—	—	—	—	+69.7%	+39.3%	+83.1%	-9.0%	-15.9%	-8.5%	-8.8%	-14.4%	-11.8%	+5.4%	+1.7%	-4.8%	+4.9%	-7.2%	-2.4%	+7.1%

Range$449.00M – $1.01B

CAGR+4.7%

Avg YoY Growth+8.0%

Median YoY Growth-3.6%

Current Streak3 quarters decline

Similar Metrics at Other Companies

StrykerSYK View metric

3MMMM View metric

Johnson & JohnsonJNJ View metric

Thermo Fisher ScientificTMO View metric

EcolabECL View metric

AppleAAPL View metric

Frequently Asked Questions

What is Merck & Co.'s asia pacific (other than china and japan) — sales?: Merck & Co. (MRK) reported asia pacific (other than china and japan) — sales of $738.00M in Q1 2026.
How has Merck & Co.'s asia pacific (other than china and japan) — sales changed year-over-year?: Merck & Co.'s asia pacific (other than china and japan) — sales increased by 7.1% year-over-year, from $689.00M to $738.00M.
What is the long-term trend for Merck & Co.'s asia pacific (other than china and japan) — sales?: Over 4 years (2021 to 2025), Merck & Co.'s asia pacific (other than china and japan) — sales has grown at a 5.5% compound annual growth rate (CAGR), from $2.41B to $2.98B.
What does asia pacific (other than china and japan) — sales mean?: Total revenue earned from sales in the Asia Pacific region, excluding Japan and China.